MétaCan
Menu
← Back to cohort
Record W7134096726

A Call for Change: Updating the Operational Definition for Dementia in Parkinson's Disease

2025· article· en· W7134096726 on OpenAlexfundno aff

Bibliographic record

VenueUCL Discovery (University College London) · 2025
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsnot available
FundersAgència de Gestió d'Ajuts Universitaris i de RecercaParkinsonfondenUniversity of California, San DiegoNational Institutes of HealthCentro de Investigación Biomédica en Red sobre Enfermedades NeurodegenerativasNational Health and Medical Research CouncilUniversitat Autònoma de BarcelonaUniversity of TorontoGeneralitat de CatalunyaCHDI FoundationUniversity of OxfordParkinson's FoundationDemensförbundetBarrow Neurological FoundationMedical Research CouncilBiogenInternational Parkinson and Movement Disorder SocietyUniversity of PennsylvaniaCurePSPU.S. Department of Veterans Affairs
KeywordsOperationalizationDementiaCognitionMedical diagnosisDiseaseIdentification (biology)Inclusion (mineral)Clinical trial
DOInot available

Abstract

fetched live from OpenAlex

In Parkinson's disease (PD), cognitive dysfunction ranges from subjective cognitive complaints to mild cognitive impairment (PD-MCI) and PD dementia (PDD). Timely identification and management of cognitive impairment are major challenges in PD, with substantial burdens on those affected and healthcare systems. Recognizing the need for criteria for different stages of cognitive impairment in PD, the Movement Disorder Society (MDS) commissioned task forces developed clinical diagnostic criteria for PDD2 (2007) and PD-MCI3 (2012) to identify cognitive impairments and ensure uniform participant criteria for therapeutic trials. The criteria, based on literature review and expert consensus, provide recommendations for diagnostic procedures that operationalize PDD4 and PD-MCI3 diagnoses and allow for Level I and II assessments (depending on available time and resources), which have both undergone formal validation. The PD-MCI criteria have not only advanced the field regarding clinical, biomarker, genetic features and the conversion to PDD, but also facilitated pathways for industry and regulatory authorities to conduct clinical trials, specifically addressing this “at risk” stage of cognitive impairment.7 At the time when the PDD criteria were established, however, there was still considerable influence from the Alzheimer's disease (AD) field and few robust biomarkers. Indeed, the only symptomatic medication approved by regulatory authorities for PDD (namely rivastigmine) used the ADAS-cog, as the primary outcome measure.8 Even recent PDD trials vary substantially in their inclusion criteria and outcome measures selected, making reliable comparisons among studies or conducting meta-analyses nearly impossible.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.255
metaresearch head score (Gemma)0.363
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.255
Threshold uncertainty score0.919

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2550.363
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0080.006
Bibliometrics0.0110.009
Science and technology studies0.0060.029
Scholarly communication0.0190.050
Open science0.0210.014
Research integrity0.0180.056
Insufficient payload (model declined to judge)0.0050.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.252
Teacher spread0.227 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designTheoretical or conceptual
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueUCL Discovery (University College London)→Same topicParkinson's Disease Mechanisms and Treatments→French-language works237,207→